Introduction
The interaction of tumors with their microenvironment has pronounced effects on cellular behavior, causing drastic changes in cell shape, binding affinity and cellular responses to soluble factors (Bissell and Radisky, 2001) , and also increasing resistance to apoptosis (Elliott and Sethi, 2002) . Usually this influence is direct, via physical contact of a tumor cell with its surrounding, such as homo-or heterocellular cell-cell interactions, or cell-substratum interactions (Hazlehurst et al., 2003a) . Proteins found in the extracellular matrix (ECM), such as fibronectin (Fn) or vitronectin (Vn), are commonly the active components of the substrate with which the tumor associates via the integrin receptor family, but it has also been speculated that some tumors can secret their own subset of ECM proteins and thus alter their microenvironment (Morin, 2003) .
The phenomenon of decreased apoptosis sensitivity caused by the tumor cells' interaction with their environment is referred to as cell adhesion-mediated drug resistance (CAM-DR; Dalton, 1999; Morin, 2003) . CAM-DR has been mainly described for hematopoietic malignancies, in particular chronic myeloid leukemia and multiple myeloma (Hazlehurst and Dalton, 2001; Shain and Dalton, 2001) , as well as various types of carcinoma (Shain and Dalton, 2001) . Three different modes of CAM-DR can be distinguished (Hazlehurst et al., 2003a ): the spheroid model in which CAM-DR is mediated by homocellular cell-cell interactions, leading to the formation of a spherical cell cluster; the stromal model where cells interact with a monolayer of stromal or feeder cells-establishing CAM-DR by heterocellular cell-cell interactions, as well as the production of soluble factors, such as secreted Fn; finally, the Fn model describes CAM-DR as being mediated by cell-substrate interactions, whereby the substrate is either the whole ECM, or a component thereof, often Fn. Although the initial form of interaction differs notably between the three models, the molecular mechanisms activated within the cells are often identical or at least similar, often converging into identical, vital survival pathways. This is in particular true for the spheroid and Fn models (Hazlehurst et al., 2003a) , for example, the Srcassociated signaling cascades, including the Raf/MEK (mitogen-activated protein kinase/ERK-kinase)/extracellular signal-regulated kinase (ERK) and (phosophatidylinositol 3 kinase (PI3K)/Akt pathways, play a crucial role in mediating survival signals initiated by both types of adhesion (Frame, 2004) .
Glioblastoma multiforme (GBM) is the most common primary brain tumor, a highly aggressive and difficult to treat malignancy, which is considered one of the most lethal cancers (Gurney and Kadan-Lottick, 2001) . The mechanisms by which GBM have acquired intrinsic apoptosis resistance are only partially understood; radiotherapy or cytotoxic chemotherapies have not significantly increased the median survival of patients over the past 10 years (Levin, 1999; Gurney and Kadan-Lottick, 2001 ). To our knowledge only two studies looked at phenomenon of CAM-DR in GBM; Cordes and Meineke (2003) found one out of four GBM cell lines investigated to exhibit a Fndependent increase in survival after irradiation, whereas a second study examined the different protective effects of Vn and Fn with respect to topoisomerase-induced apoptosis (Uhm et al., 1999) . However, understanding the molecular relationship between GBM cells and their environment is critical, as, although abnormal cellular context can contribute to tumor formation and progression, this contribution is not necessarily irreversible. Therapeutic targeting that restores the normal cellular context can lead to a restoration of apoptosis sensitivity (Bissell and Radisky, 2001) . As so little is known about CAM-DR in GBM, we investigated a possible role of CAM-DR in mediating apoptosis resistance of GBM.
Results
Effect of ECM proteins on cell number, cell cycle progression and apoptosis Before investigating the effects of ECM proteins on cytotoxic reagent-induced apoptosis we needed to know any possible effects of these substrates on spontaneous apoptosis, cell number and cell cycle progression. As depicted in Supplementary Figure 1a the spontaneous apoptosis (defined as apoptosis under 0.1% serum conditions in the absence of any additional apoptotic stimulus) did not vary substrate specifically for LN229, U87MG and U118MG cells. However, apoptosis was significantly reduced at days 2 and 3 in U373MG cells when cultured on ECM proteins compared to bovine serum albumin (BSA; Supplementary Figure 1a) , whereas on day 1 only background apoptosis could be observed (compare day 0 with day 1).
Total cell numbers were assayed by counting 48 and 96 h after seeding (day 1 and day 3, respectively). Although the number of U87MG and U118MG cells declined (Supplementary Figure 1b) , the total number of LN229 cells increased steadily, suggesting the possibility of proliferation under serum withdrawal. U373MG cell numbers decreased more rapidly when cells were plated on BSA compared to ECM proteins, preceding any measurable difference in apoptosis by at least 24 h ( Supplementary Figures 1a and b) . These findings suggest that the ECM proteins increase the total cell number of U373MG cells. To confirm this, cell-cycle distribution was analysed. As shown in Supplementary  Figure 1c , only U373MG cells showed a substratespecific difference. Thus, of the GBM cell lines investigated, only U373MG cells exhibited reduced spontaneous apoptosis and increased progression through the cell cycle when cultured on ECM proteins, corresponding to substrate-specific alterations in total cell numbers.
Next, substrate-specific CAM-DR in response to death receptor-mediated apoptosis was assayed using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), as a prototypical member of the tumor necrosis factor (TNF) family of cytokines. U87MG, U118MG and LN229 cells were exposed to different concentrations of TRAIL, but not U373MG cells, as they cannot be sensitized for apoptosis by TRAIL (data not shown and Knight et al., 2001) . Surprisingly, no significant difference in TRAIL-induced apoptosis was found between cells plated on ECM proteins and those on BSA (Figure 1a) , with the exception of U118MG cells. Here, plating on ECM proteins provided some protection at higher TRAIL concentrations. To confirm that the prevalent absence of an effect of ECM proteins on apoptosis was not a phenomenon specific to TRAIL, we extended our study to cytotoxic drugs, using the topoisomerase II inhibitor Etoposide. No significant difference in cell death was observed after 48 ( Figure 1b ) or 72 h (data not shown), with the exception of U373MG cells, which were sensitized to apoptosis by ECM proteins (Figure 1b ). This might be due to Fn and Vn inducing cell cycle progression (as shown in Supplementary Figure 1d ) in these cells and thus sensitized cells to the DNA-damaging drug Etoposide. Additional measurements of cell viability did not show any substrate-specific differences for TRAIL or Etoposide treatment (data not shown). Therefore, we conclude that for the majority of GBM cell lines used in this study ECM proteins did not affect apoptosis sensitivity toward TRAIL or Etoposide when compared to the unspecific substrate BSA.
Effects of ECM proteins on cell morphology, spreading and adhesion Our findings, showing no effect of ECM proteins on apoptosis sensitivity in the majority of GBM cell lines, were rather surprising, given that ECM proteins have been reported to protect various cell types from apoptosis and clearly influenced other aspects of GBM cell behavior-such as morphology, spreading and adhesion. As cells appeared to interact stronger with Fn than with Vn, Fn was chosen to substantiate these observations. First, cells were observed for 24 h post plating by time-lapse microscopy. Although all four GBM cell lines readily spread on Fn, three cell lines-U87MG, U118MG and U373MG-did not spread on the unspecific control BSA at all, but mainly formed highly mobile, nonadherent cell aggregates; LN229 cells also formed aggregates, but to a lesser extent ( Figure 2a) .
Next, the adhesive properties of GBM cells seeded on Fn or BSA were analysed in greater detail. Figure 1 Effect of extracellular matrix (ECM) proteins on death receptor-induced or cytotoxic drug-induced apoptosis. U87MG, U118MG, U373MG and LN229 glioblastoma multiforme (GBM) cells were seeded on bovine serum albumin (BSA; 5%), vitronectin (Vn; 0.1 mg/cm 2 ) or fibronectin (Fn; 3.3 mg/cm 2 ) at 1.1À10 5 cells per cm 2 in 0.1% serum, treated with indicated concentrations of (a) tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for 24 h or (b) Etoposide for 48 h. Apoptosis was measured by fluorescence-activated cell sorting (FACS) analysis of DNA fragmentation of propidium iodide-stained nuclei. For LN229 cells Cycloheximide (1 mg/ml) was added to TRAIL. Cycloheximide on its own induced less than 6% specific apoptosis, independently of the substrate (data not shown), whereas U373MG cells were TRAIL-resistant (data not shown and described in the literature (Knight et al., 2001) percentage of apoptotic cells were not altered by the different substrates during the first 24 h). U87MG, U373MG and U118MG cells adhered weakly to the control substrate BSA even after 24 h, whereas LN229 cells exhibited considerable unspecific adhesion. Taken together these experiments show that Fn had a profound effect on cell morphology, cell spreading and cell adhesion in GBM cells.
Effects of ECM proteins on potential survival signaling As ECM had a clear effect on some aspects of cellular behavior, such as morphology, spreading and adhesion, but not on apoptosis sensitivity, we investigated whether survival pathways associated with ECM-induced integrin clustering, such as Raf/MEK/ERK and PI3K/Akt signaling cascade, showed substrate-dependent differences in activation. Although no overall pattern of global differences in Raf/MEK/ERK or PI3K/Akt signaling could be identified between cells seeded on ECM proteins or BSA (Supplementary Figure 2a) , altered subcellular distribution of ERK between cells seeded on Fn or BSA could be identified by confocal laser microscopy (data not shown). The difference in subcellular localization of this signaling molecule suggests that the Raf/MEK/ERK pathway is initiated in a substrate-dependent manner, whereas the absence of substrate-specific difference in the total activity of the two pathways investigated (as suggested by the western blot analysis) suggests that the Raf/MEK/ERK and/or the PI3K/Akt pathway can be active even in the absence of ECM proteins.
Fn secretion of GBM cells
A possible reason for the absence of a clear effect of ECM proteins on survival, while simultaneously clearly affecting other aspects of cellular behavior, such as morphology, spreading, adhesion and the subcellular localization of molecules important for survival signaling, could be that the cell lines produce and secrete their own ECM components, in particular, because GBM cell lines have been described to produce and secrete Fn (Belot et al., 2001) . By comparison, Vn expression in GBM cells is reported stimulated by the cerebral microenvironment (Gladson et al., 1995) , and hence is rarely found in vitro. Thus, the presence of soluble Fn secreted by GBM cells could explain the apparent discrepancy between the effect of matrix-bound Fn on morphology, spreading and adhesion and the absence of any effect on apoptosis sensitivity. To address this question, we analysed the amount of Fn secreted by GBM cells (Figure 2c ). Fn production varied widely between the four cell lines investigated, but only U118MG cells produced sufficient quantity of Fn (2.2 ± 1.3 and 7.4 ± 4.3 mg/ml, corresponding to 293.6±68.8 and 922.1±300.1 ng/mg DNA shown in Figure 2c ) to reach a concentration just within the spectrum described for soluble Fn to influence cellular behavior (0.5-50 mg/ml, according to the manufacturer). Therefore, the hypothesis that GBM cell lines plated on BSA exhibited CAM-DR due to secreted Fn seems, with a possible exception of U118MG cells, an unlikely explanation for the absence of ECM-mediated apoptosis resistance.
Role of cell-cell interactions in CAM-DR of GBM cells Next, we tested the possibility that in the absence of ECM apoptosis, resistance of GBM cells is mediated not by cell-substratum, but by cell-cell interactions induced by cell clustering, as seen in Figure 2a . The two cell lines, which form the most pronounced cell aggregates on BSA, U87MG and U118MG, were chosen to address this point further. Different possibilities of inhibiting cell-cell interactions of cells seeded on BSA were assayed for the efficiency (Figure 3a) . Initially a crude measure, that is, reducing the cell density, was employed to prevent cell-cell interactions and the formation of cell aggregation (Figure 3a, second row) . A different, reduced incubation time was needed here, as these cells were already highly apoptotic, even in the absence of an additional stimulus. Nevertheless, both cell lines were significantly sensitized to TRAIL-induced apoptosis when cultured under low cell density (Figure 3b ). To clearly identify the molecules involved in cell-cell interactions we decided to use (bio)chemical inhibitors. Utilizing the ion-chelator EDTA, ion-dependence of the cell-cell interactions was shown (Supplementary Figure  2b) . Whereas the addition of an inhibitory antibody mix only weakly inhibited cell-cell interactions (Supplementary Figure 2b ), adding carbenoxyolone (CBX)-a well characterized inhibitor (Goldberg et al., 1996) of ion sensitive gap junctions (Wei et al., 2005) -strongly reduced this contact, while its functionally inactive analogue glycyrrhizic acid (GZA; Davidson et al., 1986) had no effect (Figure 3a , third and fourth row, respectively). Thus, we used CBX and GZA for further investigations into the inhibition of cell-cell interactions and its effect on apoptosis sensitivity. Crucially, CBX, but not its inactive analogue GZA, significantly sensitized U87MG and U118MG cells to TRAIL-and CD95-induced apoptosis (Figure 3c ), whereas a weaker sensitization to Etoposide could also be observed (Figure 3c ). The strong sensitization for death-receptor-mediated apoptosis was not due to changes in the surface expression of these receptors, as we found no substantial increase in surface expression of agonistic TRAIL-receptors or CD95, or downregulation of antagonistic TRAIL-receptors (data not shown). Although temozolomide (TMZ) is frequently the first treatment of choice in the clinic, no sensitization to TMZ-induced apoptosis was observed, but cells were already relatively resistant to this cytotoxic agent ( Figure 3c ). As the strongest sensitization by CBX was seen with TRAIL, we decided to concentrate on this cytotoxic reagent for further experiments. Using a constant concentration of TRAIL and an increasing concentration of CBX, we found that a significant sensitization for apoptosis occurred when cell clusters began to disperse (Figure 3d) . As shown by photographic documentation, there is a clear correlation between the concentration of CBX, which significantly sensitizes cells for apoptosis, and the dispersal of the cell clusters. Notably, as reduced proliferation in response to connexin overexpression has been described for GBM cells (Huang et al., 1998) , inhibition of surface connexin by CBX did not lead to an increase of actively cycling GBM cells (Supplementary Figure 2c) , and thus the effect on apoptosis is unlikely to be mediated simply an effect on the cell cycle.
To further verify this presumed role of gap junctions in GBM cells a more specific mode of inhibition was considered. As connexins have been associated with various pro-and antiapoptotic signaling events independently of their role in gap junction formation (Huang et al., 1998; Krysko et al., 2005) neither knockout cells, nor downregulation via RNAi seemed a suitable tool to address the role of gap junctions. Thus, the Gap 27 Cx37,43 peptide (Gap 27 peptide) was selected, it is an analogue of the extracellular loop 2 of connexins 37 and 43 and thus an effective and specific gap junction blocker. Intriguingly, Gap 27 peptide, but not its inactive control Gap 27 (Cx37,43) scrambled (scrambled peptide) inhibited cell-cell contacts (Figure 3a , fifth and sixth row, respectively). To investigate the effect of the Gap 27 peptide on apoptosis, we utilized TRAIL as a prototypic death ligand, as this showed the strongest sensitization under low cell density or in the presence of CBX. Importantly, we found that the presence of Gap 27 peptide led to a significant sensitization of U87MG and U118MG cells for TRAIL-induced apoptosis (Figure 3e) . Thus, this set of experiments shows that (unless stated otherwise) in 0.1% serum were treated in different ways to assay the effect of different compounds on cell-cell interactions. Seeding cells at low density (2.2 Â 10 3 per cm 2 for U87MG and 1.1 Â 10 3 per cm 2 for U118MG cells), as well as chemical inhibition by either the Gap-junction inhibitor carbenoxyolone (CBX), or the connexin-mimicking Gap 27 peptide (Gap 27) blocked the formation of cell-cell interactions to varying degrees. In contrast, the inactive CBX analogue glycyrrhizic acid (GZA), or the scrambled Gap 27 peptide (scrambled) had no effect on cell-cell interactions (chemicals at 100 mM, peptides at 500 mM). Pictures were taken after 28 h for cells seeded at low density and 48 h for all others. Bar: 0.2 mm. (b) Inhibition of cell-cell interactions by low density sensitizes cells for apoptosis. U87MG (upper panel) and U118MG (lower panel) cells were grown for 4 h under low cell density conditions (2.2 Â 10 3 per cm 2 for U87MG and 1.1 Â 10 3 per cm 2 for U118MG cells, in 0.1% serum) on BSA or fibronectin (Fn) and treated with the indicated substances for 24 h. Due to the high spontaneous apoptosis at low density and serum starvation a 4 h period of serum starvation was chosen instead of a 24 h period used in experiments under high cell density. (c) Inhibition of cell-cell interactions by CBX sensitizes cells for apoptosis. U87MG and U118MG cells (1.1 Â 10 5 cells per cm 2 in 0.1% serum) were cultured for 24 h in BSA in the absence or the presence of CBX prior to treatment. CBX (100 mM), or the inactive analogue GZA (100 mM), were used 24 h prior to and during the treatment with the indicated substances for 24 h, or for 48 h in the case of Etoposide. Although the presence of GZA did not significantly alter the spontaneous apoptosis of either cell line, the presence of CBX increased spontaneous apoptosis of U87MG cells by 10-15%, while not significantly affecting U118MG cells. (d) Aggregate formation and reduced sensitivity toward tumor necrosis factor-related apoptosisinducing ligand (TRAIL) are linked. Different concentrations of CBX in combination with 0.5 ng/ml TRAIL were investigated to identify the minimal concentration of the inhibitor which still had a sensitizing effect. Cells were cultured with CBX 24 h prior to treatment and for an additional 24 h in the presence of TRAIL. (e) Inhibition of cell-cell interactions by Gap 27 peptide sensitizes cells for apoptosis U87MG and U118MG cells (1.1 Â 10 5 cells per cm 2 in 0.1% serum) were cultured for 24 h on BSA in the absence or the presence of the connexin-inhibiting Gap 27 peptide (500 mM) or the inactive scrambled peptide (500 mM ) prior to treatment with 0.5 ng/ ml of TRAIL for 24 h. Addition of either peptide did not significantly alter the spontaneous apoptosis of U87MG and U118MG cells. In (a) representative pictures of two independent experiments are shown. In (b-e), the mean þ s.d. of three independent experiments performed in triplicate are depicted; apoptosis was determined by fluorescence-activated cell sorting (FACS) analysis of DNA fragmentation of propidium iodidestained nuclei. Statistical significance was determined by Student's t-test (*Po0.05; **Po0.005; # Po0.001), comparing apoptosis in the presence of Fn to BSA in (b), apoptosis in the presence of CBX to GZA in (c) and to untreated controls in (d). In (e) apoptosis in the presence of Gap 27 peptide was compared to apoptosis in the presence of scrambled peptide.
blocking cell-cell interactions by preventing the formation of gap junctions, either by seeding cells at a low density or by directly inhibiting gap junction with CBX or Gap 27 peptide, significantly increased the sensitivity of U87 and U118MG GBM cells to death-receptormediated apoptosis.
Finally, we expanded the panel of GBM cells investigated for the effects of CBX to additional GBM cell lines as well as primary GBM cells. In all cases, addition of CBX had a profound and significant effect on apoptosis sensitivity, either in sensitizing for stimulus-induced apoptosis (Figures 4a-c) , or in already sensitizing cells for apoptosis per se (Figures 4d-f) . These findings suggest that cell-cell interactions can substitute for cell-substrate interactions in conferring apoptosis resistance in GBM cells.
Discussion
The phenomenon of CAM-DR has been suggested as a possible cause for failure of many therapies, that showed promise in vitro, to live up to their potential in vivo. Although it has been well studied in cells of the hemopoietic and epithelial lineages (Hazlehurst et al., 2003a) , only little work has been done to clarify its role in GBM.
In this study we identified a novel alteration in the predominant form of CAM-DR in GBM cell lines, depending on whether a microenvironmental cue is provided (Figure 5a ). Our findings suggest that the apparent absence of an antiapoptotic effect of ECM is due to the GBM cells' ability to alternate between different forms of CAM-DR, from an ECM-mediated form of CAM-DR (in the presence of a supporting substratum) to a spheroid-based form of CAM-DR (in the absence of a suitable substrate). Sphere formation is an effective protection from a variety of apoptotic stimuli, among them irradiation and anticancer drugs, such as Etoposide, to which outer cells of a sphere can be up to 10 times more resistant than the same cells grown as a monolayer Sutherland and Durand, 1972; Oloumi et al., 2000; Hazlehurst et al., 2003a) .
In accordance with this model cell-substratum and cell-cell interactions have to be inhibited to sensitize GBM cells to apoptosis (Figure 5b ). This conclusion is supported by three independent lines of investigation. Firstly, lowering the cell density in the absence of cellsubstratum interactions, so that only a small percentage of cells were able to interact increased the percentage of apoptotic GBM cells after exposure to TRAIL. Secondly, we identified intercellular connexin tunnels called gap junctions as key mediators of cell-cell interactions involved in spheroid-mediated CAM-DR. Accordingly, chemical inhibition of gap junctions using CBX, a relatively specific chemical inhibitor of gap junctions, led to a significant sensitization for death receptor-mediated apoptosis. Thirdly, incubation with the specific Gap 27 peptide, which directly mimics part of the connexin molecule and thus inhibits the formation of gap junctions, also led to a sensitization for TRAILinduced apoptosis. Thus, only after inhibition of both modes of interactions (cell-substrate and cell-cell) can a significant sensitization of GBM cells for apoptosis be observed.
Gap junctions have been previously described to mediate homocellular GBM interactions (Oliveira et al., 2005) . Although inhibition of gap junctions with either CBX or the Gap 27 peptide seems to be sufficient to disrupt cell-cell interactions in GBM, they are usually associated with additional cell adhesion molecules (such as N-cadherin) and it has been suggested that gap junctions alone are not sufficient to form stable cell-cell interactions (Davidson et al., 1986) . It is possible that they either support and strengthen the cell-cell interactions mediated by another protein, or that gap junctions themselves protect cells from apoptosis by diluting the apoptotic signal. The precise role of gap junctions in CAM-DR of GBM cells will be subjected to further investigation. It should also be pointed out that the role of gap junctions in apoptosis is a complex one and cannot be simply equated to the role of connexin (Krysko et al., 2005) .
It has been previously demonstrated that CAM-DR can be mediated via different routes in cells of identical origin. For example, CAM-DR in multiple myeloma cell lines can be achieved by either heterocellular cell-cell interactions, that is, co-culturing with bone marrow stromal cells (Schmidmaier et al., 2004) , or by cellsubstrate interactions, that is, seeding the cells on Fn (Hazlehurst et al., 2003b) . However, our study is the first to show that a particular tumor cell type (GBM cells) can alter its mode of CAM-DR depending whether an environmental cue is provided (the presence of ECM) or not (the absence of ECM). It remains to be elucidated whether this behavior in CAM-DR is a feature specific to GBM cells. In comparison, cancers derived from epithelial cells, such as carcinomas, show a particular dependence on adhesion to substrate, often resulting in anoikis upon removal of their microenvironment, in contrast to tumor cells of hemopoietic lineage, which exhibit a more flexible interaction with their microenvironment (Hazlehurst et al., 2003a; Schmidmaier et al., 2004; Krysko et al., 2005) . GBM cells, similar to gap junction-utilizing neural progenitor cells (NPCs; Cheng et al., 2004) , from which they are believed to Additional glioblastoma multiforme (GBM) cells sensitized by carbenoxyolone (CBX) for apoptosis. All GBM cells were seeded on bovine serum albumin (BSA; 5%) at 1.1 Â 10 5 cells per cm 2 in 0.1% serum and cultured in the absence or presence of CBX. In (a-e) 100 mM CBX, or the inactive analogue glycyrrhizic acid (GZA; 100 mM), were used and in (f) 10 times higher concentrations of the substances were used, as 1 mM CBX was needed to dissolve the cell clusters. (a-c) CBX sensitizes GBM cells for induced apoptosis. All cells were cultured in the presence of CBX or GZA for 24 h prior to treatment, as well as during the time of treatment. (a) The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant U373 cell lines were treated with 100 mg/ml Etoposide for 48 h, whereas T98G cells (b) and primary GBM cells (c) were treated with 1 or 0.5 ng/ml TRAIL, respectively. CBX did not increase spontaneous apoptosis more than a maximum of 10% in any cell population. (d-f) CBX sensitizes a subset of GBM cell lines for apoptosis per se. A172 (a), LN18 (b) and LN229 (c) cells were incubated are sensitized for apoptosis by CBX per se. Cells were cultured for 48 h in the presence of CBX or GZA. The mean þ s.d. of three independent experiments performed in triplicate are depicted, apoptosis was determined by fluorescence-activated cell sorting (FACS) analysis of DNA fragmentation of propidium iodide-stained nuclei. In (a-c) specific apoptosis is shown, where CBX did not increase spontaneous apoptosis more than a maximum of 10%, whereas in (d-f) spontaneous apoptosis is depicted. Statistical significance was determined by Student's t-test (*Po0.05; # Po0.001), comparing apoptosis in the presence of CBX to GZA.
derive (Sanai et al., 2005) , are highly motile and able to form sphere-like structures, whereas the same cells invading the surrounding tissue, either as individual cells or at the tumor periphery, are often found to be associated with ECM (Bellail et al., 2004) . Interestingly, the aggregates formed by GBM cells not only resemble neurospheres, but they also behave similarly. Accordingly, transferring these GBM cell clusters onto Fn led to cell disassociation and monolayer growth (Supplementary Figure 3c) . Similarly, the transference of neurospheres onto Fn is an established method to grow NPCs as monolayers (Calaora et al., 2001) . Further experiments will be needed to determine whether the observed change in CAM-DR modes in GBM cells is related to specific properties inherent to their progenitor cells.
Of additional interest is the fact that we have identified a subset of GBM cell lines, which undergo apoptosis in the presence of CBX without the need for an additional stimulus, a process highly reminiscent of anoikis. The genetic differences between those two types of GBM lines (those which are sensitized for apoptosis by inhibition of gap junctions versus those which undergo apoptosis when gap junctions are inhibited) will be subject to further studies, as it might also shed light onto which mechanisms (possibly mutations or reactivation of programs inherent to the progenitor cells) reduce the sensitization of GBM cells for the intrinsic, drug-induced apoptosis pathway and, intriguingly, whether there is a common link between anoikis resistance and relative resistance to drug-induced apoptosis. However, in the absence of a suitable substratum (that is, in the presence of bovine serum albumin (BSA)) these cells neither undergo anoikis, nor exhibit a more apoptosis-sensitive phenotype. Instead they form dense cell aggregates, similar to neurospheres of neural progenitor cells (NPCs) or the cell clusters formed by astrocytoma cancer stem cells (Galli et al., 2004; Singh et al., 2004; Yuan et al., 2004) , and are thus protected from apoptosis via the spheroid mode of CAM-DR. (b) The potential role of gap junctions in GBM cell-cell interactions. Cluster formation of GBM cells leads to increased apoptosis resistance, as shown in the first column. We identified intercellular connexin clusters known as gap junctions as main contributors to sphere formation and thus mediators of spheroid-CAM-DR. Blocking gap junction formation leads to inhibition of cell-cell interactions and thus sensitizes for apoptosis (second column).
Although it has been frequently shown that the expression of connexin 43 (the most abundantly expressed connexin in the brain) correlates inversely with the astrocytoma tumor degree (Soroceanu et al., 2001) , it remains to be pointed out that most studies also demonstrate that GBM still form fully functional gap junctions, suggesting evolutionary pressure to prevent a complete loss of connexin expression. Indeed, recent studies suggest an important role of heterocellular gap junctions between astrocytes and GBM cells in invasion (Zhang et al., 1999; Oliveira et al., 2005) . Although homocellular interactions between GBM cells have been also described (Oliveira et al., 2005) , their potential contribution to GBM biology had not been investigated. The role of gap junctions in apoptosis signaling is a complex one, as both, cell-death and cell-survival signals, can spread between cells via this route (Krysko et al., 2005) . Although gap junction-mediated apoptosis resistance has been described in other cell systems (Green et al., 2005) , this study is, to our knowledge, the first to address this phenomenon in GBM cells.
GBM is a highly aggressive tumor that often does not respond to most available treatments. New therapeutic approaches are therefore needed to improve patients' quantity and quality of life. Our findings suggest that inhibition of cell-substrate interactions is unlikely to sensitize GBM per se to treatment, for example, TRAILinduced apoptosis. By demonstrating that GBM cells exhibit an environment-dependent alteration in their preferred mode of CAM-DR and that both cellsubstrate and cell-cell interactions must be blocked to enhance apoptosis sensitivity of these cells, our findings have important implications for the development of novel approaches in the treatment of GBM.
Materials and methods
Cell lines and culture condition All GBM cell lines were obtained from ATCC (Manassas, VA, USA). GBM no. 2 was cultured from a surgical specimen kindly provided by V Braun, Ev. Jung-Stilling-Krankenhaus Siegen, Germany. Cells were regularly passaged with buffered 0.05% trypsin/0.5 mM EDTA (Biochrom AG, Berlin, Germany) and maintained in plastic culture flasks (BD Biosciences, Heidelberg, Germany) with Dulbecco's modified Eagle's medium supplemented with 2% L-glutamine and 2% antibiotics (penicillin/streptomycine; all obtained from Invitrogen, Karlsruhe, Germany), as well as 10% fetal calf serum (Biochrom AG).
All four main cell lines expressed integrins (that is, were able to interact with the ECM proteins) and the optimal serum concentration (0.1%) that did not affect the specific cell-ECM interactions was determined (Supplementary Figures 3a and  b) . Nonadherent control cells had neither undergone anoikis, nor were irrevocably altered in their adhesion properties (shown for U87MG cells in Supplementary Figure 3c) . Experimental cells were seeded at a density of 1.1 Â 10 5 cells per cm 2 in 0.1% serum for 24 h, unless stated otherwise. Lowdensity experiments were performed at concentrations of 2.2 Â 10 3 and 1.1 Â 10
Fn and Vn coating
Tissue culture plates were covered either with a 5% BSA solution, 0.1 mg/cm 2 human Vn (Sigma-Aldrich) or with 3.3 mg/cm 2 human Fn (Sigma-Aldrich), as suggested by the manufacturer, and incubated at 4 1C overnight before use.
Determination of apoptosis
Apoptosis analysis was performed as previously described (Fulda et al., 1997) . Briefly, cells were permeabilized and incubated overnight in a propidium iodide solution (0.1% trisodiumcitrat-dihydrat, 0.4% Triton X, 50 mg/ml propidium iodide; Sigma-Aldrich). DNA fragmentation of propidium iodide-stained nuclei was analysed by fluorescence-activated cell sorting (FACS). Specific apoptosis was calculated using the following formula: (observed apoptosisÀspontaneous apoptosis) Â (100/(100Àspontaneous apoptosis)), where spontaneous apoptosis was defined as apoptosis observed under low serum conditions in the absence of any additional apoptotic stimulus. To confirm that this method reflects the true extent of apoptosis within a given population and that apoptosis is indeed the main mode of cell death observed, DNA fragmentation was compared to morphological features of apoptosis (namely chromatin condensation and karyorhexis) and cell death in general (loss of cell membrane integrity), shown for TRAIL-induced cell death of U87MG cells in Supplementary Figure 3d . Cell cycle progression was also analysed from FACS profiles.
Adhesion assay
Cells were seeded on coated (BSA or Fn) plates and allowed to settle for the indicated time period (2, 10 or 24 h). The plates were washed with phosphate buffered saline, and after the remaining liquid was aspirated cells were trypsinized. At a given time point cells and supernatant were collected and vortexed to avoid cell clusters. The samples were then diluted in CASYton dilution liquid (Scha¨rfe System, Reutlingen, Germany) and measured using a CASY I DT cell counter (Scha¨rfe System).
Protein immunoblotting
Western blot analysis was performed as previously described (Westhoff et al., 2004) . Briefly, after lysis and determination of protein concentration, samples were separated on a 10% SDSpolyacrylamide gel electrophoresis gel and transferred onto Hybond ECL nitrocellulose membrane (Amersham Biosciences, Freiburg, Germany). Proteins were visualized by ECL western blotting detection reagents (Amersham Biosciences), according to the manufacturer's instructions.
Quantitative determination of Fn synthesis Fn synthesis was assayed by time-resolved fluorescence immunoassay as previously described (Schmid-Kotsas et al., 1999) . Briefly, supernatants were incubated with mouse monoclonal anti-c-Fn (1:1000), followed by incubation with a secondary antibody (biotin-labeled anti-mouse IgG diluted 1:1000) and europium-labeled strepavidin (1:1000). Timeresolved fluorescence of the europium chelate was measured using a Victor 1420 Multilabel Counter (PerkinElmer, Rodgau-Juegesheim, Germany). DNA was quantified by fluorometry, using bisbenzimide as previously described (Labarca and Paigen, 1980) . Calf thymus DNA was used as a standard and fluorescence (l: 350, 450 nm) was measured by a Victor 1420 Multilabel Counter.
Analysis of cell-cell interactions
Cells were seeded on a BSA-treated well of a chamber glass slide (BD Biosciences) and either 100 mM of the specific inhibitor of gap junctions CBX (or its inactive analogue GZA), or 500 mM of the Gap 27 Cx37,43 peptide (or its inactive control) was added to the suspension. Photos were taken after 48 h (corresponding to day 1) under a CK40 microscope with a CAMEDIA C-4040ZOOM digital camera (both Olympus, Hamburg, Germany).
Statistical analysis
Statistical significance was determined by the (two-population, independent) Student's t-test (*Po0.05; **Po0.005; # Po0.001).
